AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/141
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA - SINGLE-CENTER EXPERIENCE OF 97 PATIENTS
Authors: MEHTA J AYERS D MATTOX S SINGHAL S SIEGEL D FASSAS A HILTON J ANAISSIE E DESIKAN K MUNSHI N JAGANNATH S TRICOT G BARLOGIE B
Citation: J. Mehta et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA - SINGLE-CENTER EXPERIENCE OF 97 PATIENTS, Blood, 90(10), 1997, pp. 993-993
SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/
Authors: DESIKAN KR FASSAS A SIEGEL D JAGANNATH S MEHTA J SINGHAL S BRACY D TRICOT G BARLOGIE B
Citation: Kr. Desikan et al., SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/, Blood, 90(10), 1997, pp. 1016-1016
PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION WITH G-CSF ALONE IN MULTIPLE-MYELOMA (MM) - FACTORS ASSOCIATED WITH POST TRANSPLANT (TX) RECOVERY
Authors: DESIKAN KR MEHTA J FASSAS A SIEGEL D MUNSHI N SINGHAL S JAGANNATH S TRICOT G BARLOGIE B
Citation: Kr. Desikan et al., PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION WITH G-CSF ALONE IN MULTIPLE-MYELOMA (MM) - FACTORS ASSOCIATED WITH POST TRANSPLANT (TX) RECOVERY, Blood, 90(10), 1997, pp. 1017-1017
AUTOPSY REVIEW IN MULTIPLE-MYELOMA (MM) REVEALS ASPERGILLOSIS (ASP) AS A SIGNIFICANT CAUSE OF DEATH AFTER HIGH-DOSE THERAPY (HDT) ESPECIALLY WITH ALLOTRANSPLANTS (ALLO-TX)
Authors: KONERU B HOUGH A FASSAS A TRICOT G DESIKAN KR SIEGEL D JAGANNATH S SINGHAL S MEHTA J BARLOGIE B ANAISSIE E
Citation: B. Koneru et al., AUTOPSY REVIEW IN MULTIPLE-MYELOMA (MM) REVEALS ASPERGILLOSIS (ASP) AS A SIGNIFICANT CAUSE OF DEATH AFTER HIGH-DOSE THERAPY (HDT) ESPECIALLY WITH ALLOTRANSPLANTS (ALLO-TX), Blood, 90(10), 1997, pp. 1573-1573
SIGNIFICANCE OF RECOVERY OF UNINVOLVED IMMUNOGLOBULINS (UIG) FOLLOWING TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM)
Authors: MUNSHI NC JAGANNATH S DESIKAN K MEHTA J SINGHAL S SIEGLE S FASSAS A AYERS D MATTOX S ANAISSIE A TRICOT G BARLOGIE B
Citation: Nc. Munshi et al., SIGNIFICANCE OF RECOVERY OF UNINVOLVED IMMUNOGLOBULINS (UIG) FOLLOWING TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS IN NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 1574-1574
SECONDARY NEOPLASMS (SN) FOLLOWING AUTO-TRANSPLANTS (AT) FOR MULTIPLE-MYELOMA (MM)
Authors: GOVINDARAJAN R TRICOT G JAGANNATH S FLICK JT SAWYER J AYERS D BARLOGIE B
Citation: R. Govindarajan et al., SECONDARY NEOPLASMS (SN) FOLLOWING AUTO-TRANSPLANTS (AT) FOR MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 1687-1687
FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S VESOLE D SIEGEL D DESIKAN KR MUNSHI N FASSAS A SINGHAL S MEHTA J SPOON D TRICOT G EVANS T NAUCKE S TINDLE S NELSON J COPELAND N BARLOGIE B
Citation: S. Jagannath et al., FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 1860-1860
SIMILAR PROGNOSIS AFTER TANDEM AUTOTRANSPLANTS (TAT) FOR MYELOMA LESS-THAN-65 YR AND GREATER-THAN-OR-EQUAL-TO-65 YR
Authors: SIEGEL D JAGANNATH S DESIKAN KR TRICOT G VESOLE D FASSAS A SINGHAL S MEHTA J HOOD S BARLOGIE B
Citation: D. Siegel et al., SIMILAR PROGNOSIS AFTER TANDEM AUTOTRANSPLANTS (TAT) FOR MYELOMA LESS-THAN-65 YR AND GREATER-THAN-OR-EQUAL-TO-65 YR, Blood, 90(10), 1997, pp. 1861-1861
HIGH-DOSE MELPHALAN AND AUTOTRANSPLANTATION IN MYELOMA WITH RENAL IMPAIRMENT - A MATCHED-PAIR COMPARISON WITH PATIENTS WITHOUT RENAL-FAILURE
Authors: MEHTA J AYERS D MATTOX S SINGH J SINGHAL S SIEGEL D FASSAS A DESIKAN K VESOLE D MUNSHI N ANAISSIE E TRICOT G BARLOGIE B JAGANNATH S
Citation: J. Mehta et al., HIGH-DOSE MELPHALAN AND AUTOTRANSPLANTATION IN MYELOMA WITH RENAL IMPAIRMENT - A MATCHED-PAIR COMPARISON WITH PATIENTS WITHOUT RENAL-FAILURE, Blood, 90(10), 1997, pp. 1863-1863
TUMOR LYSIS SYNDROME (TLS) FOLLOWING INTERMEDIATE AND HIGH-DOSE THERAPY IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) - ASSOCIATION WITH HIGH TUMOR MASS, IMMATURE MORPHOLOGY, HIGH LABELING INDEX (LI) AND ABNORMAL CYTOGENETICS (CG)
Authors: FASSAS A DESIKAN KR GOLPER T SIEGEL D SINGHAL S MEHTA J MATTOX S JAGANNATH S TRICOT G BARLOGIE B
Citation: A. Fassas et al., TUMOR LYSIS SYNDROME (TLS) FOLLOWING INTERMEDIATE AND HIGH-DOSE THERAPY IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) - ASSOCIATION WITH HIGH TUMOR MASS, IMMATURE MORPHOLOGY, HIGH LABELING INDEX (LI) AND ABNORMAL CYTOGENETICS (CG), Blood, 90(10), 1997, pp. 2347-2347
3RD TRANSPLANTS FOR MYELOMA RELAPSING AFTER 2 PRIOR AUTOGRAFTS
Authors: SINGHAL S MEHTA J HOOD S MATTOX S SIEGEL D FASSAS A DESIKAN K ANAISSIE E TRICOT G JAGANNATH S BARLOGIE B
Citation: S. Singhal et al., 3RD TRANSPLANTS FOR MYELOMA RELAPSING AFTER 2 PRIOR AUTOGRAFTS, Blood, 90(10), 1997, pp. 2436-2436
COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS AFTER A PRECEDING AUTOTRANSPLANT
Authors: SINGHAL S HOOD S MEHTA J SIEGEL D FASSAS A DESIKAN K NELSON J TINDLE S JAGANNATH S TRICOT G BARLOGIE B
Citation: S. Singhal et al., COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS AFTER A PRECEDING AUTOTRANSPLANT, Blood, 90(10), 1997, pp. 2438-2438
THYMIDINE KINASE (TK) GENE-TRANSDUCED HUMAN-LYMPHOCYTES CAN BE HIGHLYPURIFIED, REMAIN FULLY FUNCTIONAL, AND ARE KILLED EFFICIENTLY WITH GANCICLOVIR
Authors: MUNSHI NC GOVINDARAJAN R DRAKE R DING LM IYER R SAYLORS R KORNBLUTH J MARCUS S CHIANG Y ENNIST D KWAK L REYNOLDS C TRICOT G BARLOGIE B
Citation: Nc. Munshi et al., THYMIDINE KINASE (TK) GENE-TRANSDUCED HUMAN-LYMPHOCYTES CAN BE HIGHLYPURIFIED, REMAIN FULLY FUNCTIONAL, AND ARE KILLED EFFICIENTLY WITH GANCICLOVIR, Blood, 89(4), 1997, pp. 1334-1340
SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S VESOLE DH NAUCKE S CHESON B MATTOX S BRACY D SALMON S JACOBSON J CROWLEY J TRICOT G
Citation: B. Barlogie et al., SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA, Blood, 89(3), 1997, pp. 789-793
SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY
Authors: TRICOT G ALBERTS DS JOHNSON C ROE DJ DORR RT BRACY D VESOLE DH JAGANNATH S MEYERS R BARLOGIE B
Citation: G. Tricot et al., SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY, Clinical cancer research, 2(6), 1996, pp. 947-952
RETROVIRAL GENE-TRANSFER IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE-LEUKEMIA
Authors: CORNETTA K SROUR EF MOORE A DAVIDSON A BROUN ER HROMAS R MOEN RC MORGAN RA RUBIN L ANDERSON WF HOFFMAN R TRICOT G
Citation: K. Cornetta et al., RETROVIRAL GENE-TRANSFER IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE-LEUKEMIA, Human gene therapy, 7(11), 1996, pp. 1323-1329
HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: TRICOT G JAGANNATH S VESOLE DH BRACY D DESIKAN KR SIEGEL D BARLOGIE B
Citation: G. Tricot et al., HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA, Leukemia & lymphoma, 22(1-2), 1996, pp. 25-36
AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA
Authors: VESOLE DH JAGANNATH S TRICOT G DESIKAN KR SIEGEL D BARLOGIE B
Citation: Dh. Vesole et al., AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA, Cancer investigation, 14(4), 1996, pp. 378-391
MINIMIZING GRAFT-REJECTION IN ALLOGENEIC T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION
Authors: RIGDEN JP CORNETTA K SROUR EF HANNA M BROUN ER HROMAS R BAUTE J HILTON J COX E RUBIN L GONIN R TRICOT G
Citation: Jp. Rigden et al., MINIMIZING GRAFT-REJECTION IN ALLOGENEIC T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(5), 1996, pp. 913-919
TIAZOFURIN - MOLECULAR AND CLINICAL ACTION
Authors: WEBER G PRAJDA N ABONYI M LOOK KY TRICOT G
Citation: G. Weber et al., TIAZOFURIN - MOLECULAR AND CLINICAL ACTION, Anticancer research, 16(6A), 1996, pp. 3313-3322
BIOCHEMICALLY TARGETED THERAPY OF REFRACTORY LEUKEMIA AND MYELOID BLAST CRISIS OF CHRONIC GRANULOCYTIC-LEUKEMIA WITH TIAZOFURIN, A SELECTIVE BLOCKER OF INOSINE 5'-PHOSPHATE DEHYDROGENASE-ACTIVITY
Authors: TRICOT G WEBER G
Citation: G. Tricot et G. Weber, BIOCHEMICALLY TARGETED THERAPY OF REFRACTORY LEUKEMIA AND MYELOID BLAST CRISIS OF CHRONIC GRANULOCYTIC-LEUKEMIA WITH TIAZOFURIN, A SELECTIVE BLOCKER OF INOSINE 5'-PHOSPHATE DEHYDROGENASE-ACTIVITY, Anticancer research, 16(6A), 1996, pp. 3341-3347
PRECEDING STANDARD THERAPY IS THE LIKELY CAUSE OF MDS AFTER AUTOTRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: GOVINDARAJAN R JAGANNATH S FLICK JT VESOLE DH SAWYER J BARLOGIE B TRICOT G
Citation: R. Govindarajan et al., PRECEDING STANDARD THERAPY IS THE LIKELY CAUSE OF MDS AFTER AUTOTRANSPLANTS FOR MULTIPLE-MYELOMA, British Journal of Haematology, 95(2), 1996, pp. 349-353
AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED
Authors: VESOLE DH TRICOT G JAGANNATH S DESIKAN KR SIEGEL D BRACY D MILLER L CHESON B CROWLEY J BARLOGIE B
Citation: Dh. Vesole et al., AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED, Blood, 88(3), 1996, pp. 838-847
CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN MULTIPLE-MYELOMA
Authors: SINGHAL S SIEGEL D MATTOX S JAGANNATH S TRICOT G MEHTA J DESIKAN KR MUNSHI N ZENT C BARLOGIE B
Citation: S. Singhal et al., CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3599-3599
CHANGES IN PULMONARY-FUNCTION TEST (PFT) FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND MELPHALAN IN MULTIPLE-MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AT)
Authors: JAZIEH AR BRACY D SPINKS C SIEGEL D DESIKAN KR JAGANNATH S HILLER FC BARLOGIE B TRICOT G
Citation: Ar. Jazieh et al., CHANGES IN PULMONARY-FUNCTION TEST (PFT) FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND MELPHALAN IN MULTIPLE-MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AT), Blood, 88(10), 1996, pp. 3752-3752
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>